Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,180
datasets available to search
ShareScore release 0.9.0
Dataset results
2,180 results for “clinical outcomes”
MiRoR11 - P2 - Annotated corpus for semantic similarity of clinical trial outcomes
<p>Outcome similarity corpus</p> <p>This dataset contains annotations of semantic similarity for pairs of primary and reported outcomes.<br> Tab-separated format is used. The files contain the following columns:<br> filename, sentence pair ID, sentence pair text, primary outcome, primary outcome start position, primary outcome end position, reported outcome, reported outcome start position, reported outcome end position, label</p> <p>The folder out_relations_split contains the dataset splits for 10-fold cross-validation.</p>
TomoBreast randomized clinical trial's lung-heart outcomes and mortality through the 2020 COVID-19 pandemic: data and software
<p>Dataset and R script to reproduce the analyses of the manuscript:</p> <p>Vinh-Hung V, Gorobets O, Adriaenssens N, Van Parijs H, Storme G, Verellen D, Nguyen NP, Magne N, De Ridder M.</p> <p><strong>Lung-heart outcomes and mortality through the 2020 COVID-19 pandemic in a prospective cohort of breast cancer radiotherapy patients.</strong></p> <p>Cancers 2022; 14(24):6241. https:// doi.org/10.3390/cancers14246241</p> <p>https://www.mdpi.com/2072-6694/14/24/6241</p> <p>PubMed: PMID: 36551726</p> <p>PMCID: PMC9777311</p> <p>Info on the variables in file "aelq6_public.R"</p> <p>reproduced in "aelq_2_3_readme.txt":</p> <p>"aelq2_base2.txt" = baseline characteristics.</p> <p>"aelq3.txt" = longitudinal maesurements.</p> <p>Variables in "aelq2_base2.txt":</p> <p>"<strong>aelq2_base2.txt</strong>" = baseline characteristics. <br># Age at randomization, years. <br># RTdose: cf TomoBreast papers. <br># 51 Gy = hypofractionated, simultaneous integrated boost<br># 42 Gy = hypofractionated, no boost, mastectomy cases only<br># 50 Gy = conventional, no boost, mastectomy cases only<br># 66 Gy = conventional, sequential boost<br># Weight kg, Height cm, <br># Detection 1=found by screening (senology follow-up/controle)<br># 2=found by symptoms (pain, palpable)<br># 9=unknown<br># Smoker 0= Not smoker<br># 1= Smoker<br># 2=ex-smoker<br># Mastectomy (and other binary coded) 1= yes<br># chemosched 0=none<br># 1= planned after RT (sequential)<br># 2= prior to RT and is finished (sequential)<br># 3= chemo is on-going or is planned to start with RT (concomitant)<br># hormonetherapy 0=no<br># 1=tamoxifen (nolvadex)<br># 2=Femara (Letrozole)<br># 3=zoladex<br># 4=tamoxifen + zoladex<br># Laterality 1,=Right, 2=Left, 3=Bilateral<br># LengthFU: length of follow-up, days from randomization</p> <p>"<strong>aelq3.txt</strong>" = longitudinal maesurements.<br># "Nr" = Case ID<br># "Time" in days from origin (origin =date of randomization), <br># if negative =before randomization<br># "KPS" "Weight" <br># "Died" "LocalRec" "Metast" "NewPrim" = binary code, 0=no, 1=yes<br># "fAEBreast" "fAEHeart" "fAELung" "fAEOther" <br># fAE = freedom from breast, heart, lung, other adverse event score<br># "LVEF2" = ejection fraction, %<br># "MacIver" = estimated cardiac strain</p> <p># the following are pulmonary function tests, untransformed units<br># "FVC", "FEV1", "PEF", "VC", "TLC", "RV", "FRC", "Raw", "sRaw", "DLCO",<br># "VA", "PF"</p> <p># "fDY", "fFA", "fPA" = freedom from dyspnea, from fatigue, from pain<br># range 0 to 100 (best)<br># see papers:</p> <p># Van Parijs, H.; Vinh-Hung, V.; Fontaine, C.; Storme, G.; Verschraegen, C.;<br># Nguyen, D.M.; Adriaenssens, N.; Nguyen, N.P.; Gorobets, O.; De Ridder, M.<br># Cardiopulmonary-related patient-reported outcomes in a randomized clinical<br># trial of radiation therapy for breast cancer. BMC Cancer 2021, 21, 1177,<br># doi:10.1186/s12885-021-08916-z.</p> <p># preprint:<br># Van Parijs, H.; Cecilia-Joseph, E.; Gorobets, O.; Storme, G.; <br># Adriaenssens, N.; Heyndrickx, B.; Verschraegen, C.; Nguyen, N.P.;<br># De Ridder, M.; Vinh-Hung, V. Lung-heart toxicity in a randomized <br># clinical trial of hypofractionated image guided radiation therapy for<br># breast cancer. Preprints 2022, 202212, 0214.<br># https://doi.org/10.20944/preprints202212.0214.v1</p> <p># <br># "Year" = year of the observation<br># example: randomized 1/1/2011, measurement done 1/31/2011, time = 30 days,<br># Year =2011<br>#<br> </p>
Clinical outcome for TheraCal LC group for postoperative pain, tenderness, and neural sensibility at the patient recall period of 21 days, 3 months, and 12 months
<p>Clinical outcome for TheraCal LC group for postoperative pain, tenderness, and neural sensibility at the patient recall period of 21 days, 3 months, and 12 months</p>
Clinical outcome for MTA group for postoperative pain, tenderness, and neural sensibility at the patient recall period of 21 days, 3 months, and 12 months
<p>Clinical outcome for MTA group for postoperative pain, tenderness, and neural sensibility at the patient recall period of 21 days, 3 months, and 12 months</p>
Clinical outcome for Biodentine group for postoperative pain, tenderness, and neural sensibility at the patient recall period of 21 days, 3 months, and 12 months
<p>Clinical outcome for Biodentine group for postoperative pain, tenderness, and neural sensibility at the patient recall period of 21 days, 3 months, and 12 months</p>
Machine learning links T cell function and spatial localization to neoadjuvant immunotherapy and clinical outcome in pancreatic cancer
<p>Data supporting the findings of "<a href="https://doi.org/10.1158/2326-6066.CIR-23-0873" target="_blank" rel="noopener">Machine learning links T cell function and spatial localization to neoadjuvant immunotherapy and clinical outcome in pancreatic cancer</a>" publication. Files include patient and tissue region metadata (in metadata folder) and output of multiplex immunohistochemistry computational image processing workflow for each tissue region (in mIHC_files folder). The code used to produce the results of this study is available at: <a href="https://github.com/kblise/PDAC_mIHC_paper">https://github.com/kblise/PDAC_mIHC_paper</a>.</p>
Sempa et al. 2019 - A Retrospective audit of treatment outcomes, side-effect profiles and default and mortality rates of HIV/AIDS patients at the antiretroviral clinic at Pretoria Academic Hospital.
<p>The comprehensive demographic and long-term treatment data of the first, consecutive, 963 patients older than 18 years of age who presented for ART at the Tshwane District Hospital in Gauteng, South Africa during 2004 and 2005 were selected for analysis. All patients started ART after 2004 as part of the South African national HIV treatment plan and were treated according to the National Department of Health HIV guidelines (2004) operative at the time, i.e. eligibility for ART was CD4 <200 cells/µL or WHO stage 4 disease regardless of CD4 count. Treatment was initiated using a standardized triple-drug regimen consisting of two nucleoside reverse transcriptase inhibitors, mostly d4T and 3TC, and one non-nucleoside reverse transcriptase inhibitor, either NVP or EFV. CD4 and HIV-1 VL monitoring was performed at treatment initiation ‘baseline’ and then 6-monthly, according to the national protocol. Demographic, anthropometric, clinical, ART and 5-year longitudinal treatment response data were collected. Excluded all second-line ART visits for all patients who were switched to second-line therapy.</p>
Data of 14 participants in the RCT titled Acute effects of virtual reality exercise bike games on psychophysiological outcomes in college North-African adolescents with cerebral palsy: A randomized clinical trial
<p>It is an Excel file including the numerical data of the 14 participants included in the study titled: <a name="_Hlk151119211"></a><span>Acute effects of virtual reality exercise bike games on psychophysiological outcomes in college North-African adolescents with cerebral palsy: A randomized clinical trial</span></p>
Cancer-specific association between Tau (MAPT) and cellular pathways, clinical outcome, and drug response
<p>To bring new evidence that Tau represents a key protein in cancer, we present an <em>in silico</em> pan-cancer analysis of <em>MAPT</em> transcriptomic profile in over 10000 clinical samples and over 1300 pre-clinical samples provided by the TCGA and the DEPMAP datasets respectively.</p>
An Extension Study of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase-IT in Conjunction With Elaprase in Pediatric Participants With Hunter Syndrome and Cognitive Impairme
ClinicalTrials.gov study NCT01506141. IPD Sharing: YES. Countries: 3. Publications: 3.
Early Clinical Outcomes of High-Purity Type I Collagen as a Biologic Reinforcement in Selected Hernia Repair Scenarios
ClinicalTrials.gov study NCT07360691. IPD Sharing: YES. Countries: 1. Publications: 7.
Clinical Trial of a Supporter-Targeted Intervention to Improve Outcomes in Recent Sexual Assault Survivors
ClinicalTrials.gov study NCT05345405. IPD Sharing: YES. Countries: 1. Publications: 1.
Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes
ClinicalTrials.gov study NCT06069206. IPD Sharing: YES. Countries: 1. Publications: 18.
Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094
ClinicalTrials.gov study NCT02412787. IPD Sharing: YES. Countries: 7. Publications: 2.
Longitudinal Outcome in a Veterans Geriatric Multifactorial Falls Assessment Clinic
ClinicalTrials.gov study NCT02356211. IPD Sharing: NO. Countries: 1. Publications: 5.
Study of Relationship Between Vedolizumab Therapeutic Drug Monitoring, Biomarkers of Inflammation and Clinical Outcomes
ClinicalTrials.gov study NCT04567628. IPD Sharing: YES. Countries: 1. Publications: 1.
Effectiveness of Mannitol Use on Clinical Outcomes of Severe Traumatic Brain Injury Patients
<p>Dataset for manuscript entitled: </p> <p><span>Effectiveness of Mannitol Use on Clinical Outcomes of Severe Traumatic Brain Injury Patients</span></p>
The indirect impact of COVID-19 on major clinical outcomes of people with Parkinson's disease or atypical parkinsonism: a cohort study. Raw data
<p>Raw dataset of the study "The indirect impact of COVID-19 epidemic on major clinical outcomes of people with Parkinson’s disease (PD) or atypical parkinsonism: a cohort study"</p>
Viral mimicry response is associated with clinical outcome in pleural mesothelioma
<p>Raw data supporting the manuscript</p>
The effects of primary or secondary prevention with vitamin A supplementation on clinically important outcomes. A systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis
<p>Meta data for the review entitled "The effects of primary or secondary prevention with vitamin A supplementation on clinically important outcomes. A systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis<strong>"</strong></p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.